Nakamura Saki, Matsuo Makiko
Institute for Future Initiatives, The University of Tokyo, Tokyo, Japan.
Graduate School of Public Policy, The University of Tokyo, Tokyo, Japan.
Glob Health Med. 2025 Apr 30;7(2):127-140. doi: 10.35772/ghm.2025.01000.
Currently, there is a member-state-led discussion in the Intergovernmental Negotiating Body of the World Health Organization (WHO) to draft and negotiate a convention, agreement, or other international instrument under the Constitution of the WHO to strengthen global pandemic prevention, preparedness, and response (WHO CA+). An access and benefit-sharing (ABS) mechanism for pathogens is likely to be a key element of this instrument, as it may provide legal certainty for rapid pathogen sharing and global access to medical countermeasures against future pandemics and in some cases public health emergencies of international concern, which are expected to be provided to countries in need. A multilateral ABS mechanism may resolve issues arising from the bilateral nature of the current ABS mechanism established under the Nagoya Protocol (which requires recipients to decipher the complex web of ABS legislation, thereby preventing rapid access to pathogens), and may also improve uneven global access to medical countermeasures during pandemics. This study analyzes the ongoing WHO discussion on ABS mechanisms while reviewing other examples of such mechanisms, including those outside the health sector. Additionally, there is a growing global interest in mapping national policies on ABS, as discussions on international policies are ongoing in multiple fora. This study furthermore introduces Japan's ABS policy, which is not widely known, and explores how the new WHO mechanism could affect Japan, namely highlighting the importance and the challenges of participating in such a system for industry and academia in the context of a developed country.
目前,世界卫生组织(WHO)政府间谈判机构正在进行一场由成员国主导的讨论,旨在根据WHO章程起草并协商一项公约、协定或其他国际文书,以加强全球大流行预防、防范和应对(WHO CA+)。病原体的获取和惠益分享(ABS)机制很可能是该文书的关键要素,因为它可为病原体的快速共享以及全球获取针对未来大流行以及某些情况下国际关注的突发公共卫生事件的医疗应对措施提供法律确定性,这些应对措施预计将提供给有需要的国家。多边ABS机制可能会解决因根据《名古屋议定书》设立的现行ABS机制的双边性质而产生的问题(该机制要求接受方解读复杂的ABS立法网络,从而阻碍了对病原体的快速获取),还可能改善大流行期间全球获取医疗应对措施不均衡的状况。本研究分析了WHO目前关于ABS机制的讨论,同时回顾了此类机制的其他实例,包括卫生部门以外的实例。此外, 随着多个论坛正在进行关于国际政策的讨论,全球对梳理各国ABS政策的兴趣也与日俱增。本研究还介绍了鲜为人知的日本ABS政策,并探讨新的WHO机制可能如何影响日本,即在发达国家背景下,突出该系统对产业界和学术界的重要性以及参与其中所面临的挑战。